Markéta Žaliová
Žaliová, Markéta, 1979-
VIAF ID: 85786823 (Personal)
Permalink: http://viaf.org/viaf/85786823
Preferred Forms
- 100 0 _ ‡a Markéta Žaliová
-
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
Acute lymphoblastic leukemia with aleukemic prodrome: preleukemic dynamics and possible mechanisms of immunosurveillance | |
Characterization of leukemias with ETV6-ABL1 fusion | |
Chromosome 21 gain is dispensable for transient myeloproliferative disorder driven by a novel GATA1 mutation | |
ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype. | |
Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations | |
Human MLL/KMT2A gene exhibits a second breakpoint cluster region for recurrent MLL-USP2 fusions | |
IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. | |
Implications of delayed bone marrow aspirations at the end of treatment induction for risk stratification and outcome in children with acute lymphoblastic leukaemia | |
International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia. | |
Intragenic ERG Deletions Do Not Explain the Biology of ERG-Related Acute Lymphoblastic Leukemia. | |
Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase | |
Repurposing anthelmintic agents to eradicate resistant leukemia | |
Two novel fusion genes, AIF1L-ETV6 and ABL1-AIF1L, result together with ETV6-ABL1 from a single chromosomal rearrangement in acute lymphoblastic leukemia with prenatal origin |